Increased risk of breast cancer associated with CHEK2*1100delC

Journal of Clinical Oncology

Volumn 25, Issue 1, 2007, Pages 57-63

  Weischer, Maren ^a   Bojesen, Stig Egil ^a   Tybjærg Hansen, Anne ^a   Axelsson, Christen Kirk ^a   Nordestgaard, Børge Grønne ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 2; HORMONE; ORAL CONTRACEPTIVE AGENT; PROTEIN SERINE THREONINE KINASE;

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER GENETICS; CANCER RISK; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DENMARK; FEMALE; GENE DELETION; GENETIC RISK; GROUPS BY AGE; HETEROZYGOSITY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RISK ASSESSMENT; BREAST TUMOR; CASE CONTROL STUDY; COLORECTAL TUMOR; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; MIDDLE AGED; PROSTATE TUMOR; RISK;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DENMARK; FEMALE; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RISK;

EID: 34250315627     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.5160     Document Type: Article

References (29)

1. Bartek J, Lukas J: Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3:421-429, 2003
2. Bell DW, Varley JM, Szydlo TE, et al: Heterozygous germ line hCHK2 mutations in LiFraumeni syndrome. Science 286:2528-2531, 1999
3. Vahteristo P, Tamminen A, Karvinen P, et al: p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: Further evidence of CHK2 in inherited cancer predisposition. Cancer Res 61:5718-5722, 2001
4. CHEK2 Breast Cancer Case-Control Consortium: CHEK2*1100delC and susceptibility to breast cancer: A collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. Am J Hum Genet 74:1175-1182, 2004
5. Kilpivaara O, Bartkova J, Eerola H, et al: Correlation of CHEK2 protein expression and c1100delC mutation status with tumor characteristics among unselected breast cancer patients. Int J Cancer 113:575-580, 2005
6. Meijers-Heijboer H, van den OA, Klijn J, et al: Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31:55-59, 2002
7. Meijers-Heijboer H, Wijnen J, Vasen H, et al: The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. Am J Hum Genet 72:1308-1314, 2003
8. Oldenburg RA, Kroeze-Jansema K, Kraan J, et al: The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families. Cancer Res 63:8153-8157, 2003
9. Vahteristo P, Bartkova J, Eerola H, et al: A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 71:432-438, 2002
10. Cybulski C, Huzarski T, Gorski B, et al: A novel founder CHEK2 mutation is associated with increased prostate cancer risk. Cancer Res 64:2677-2679, 2004
11. Seppala EH, Ikonen T, Mononen N, et al: CHEK2 variants associate with hereditary prostate cancer. Br J Cancer 89:1966-1970, 2003
12. Kilpivaara O, Laiho P, Aaltonen LA, et al: CHEK2 1100delC and colorectal cancer [letter]. J Med Genet 40:e110, 2003 (suppl 10)
13. Appleyard M, Hansen AT, Jensen G, et al: The Copenhagen City Heart Study: Østerbroundersøgelsen - A book of tables with data from the first examination (1976-78) and a five year follow-up (1981-1983). Scand J Soc Med Suppl 41:1-160, 1989
14. Bojesen SE, Tybjærg-Hansen A, Nordestgaard BG: Integrin beta3 Leu33Pro homozygosity and risk of cancer. J Natl Cancer Inst 95:1150-1157, 2003
15. Schnohr P, Jensen G, Lange P, et al: The Copenhagen City Heart Study: Østerbroundersøgelsen - Tables with data from the third examination 1991-1994. Eur Heart J 3:H1-H83, 2001
16. Storm HH: The Danish Cancer Registry, a self-reporting national cancer registration system with elements of active data collection. IARC Sci Publ 95:220-236, 1991
17. Storm HH, Michelsen EV, Clemmensen IH, et al: The Danish Cancer Registry: History, content, quality and use. Dan Med Bull 44:535-539, 1997
18. Storm HH: Completeness of cancer registration in Denmark 1943-1966 and efficacy of record linkage procedures. Int J Epidemiol 17:44-49, 1988
19. Bray F, Sankila R, Ferlay J, et al: Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 38:99-166, 2002
20. Danish Breast Cancer Cooperative Group: Structure and organisation of DBCG, subchapters 3.1-3.3. http://www.dbcg.dk
21. Khoury MJ, Beaty TH, Cohen BH: Fundamentals of Genetic Epidemiology. New York, NY, Oxford University Press, 1993, pp 77-79
22. Cybulski C, Gorski B, Huzarski T, et al: CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet 75:1131-1135, 2004
23. Lichtenstein P, Holm NV, Verkasalo PK, et al: Environmental and heritable factors in the causation of cancer: Analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78-85, 2000
24. Brody LC, Biesecker BB: Breast cancer susceptibility genes: BRCA1 and BRCA2. Medicine (Baltimore) 77:208-226, 1998
25. Dufault MR, Betz B, Wappenschmidt B, et al: Limited relevance of the CHEK2 gene in hereditary breast cancer. Int J Cancer 110:320-325, 2004
26. Lipton L, Fleischmann C, Sieber OM, et al: Contribution of the CHEK2 1100delC variant to risk of multiple colorectal adenoma and carcinoma. Cancer Lett 200:149-152, 2003
27. Collado M, Landt O, Barragan E, et al: Locked nucleic acid-enhanced detection of 1100delC*CHEK2 germ-line mutation in Spanish patients with hematologic malignancies. Clin Chem 50:2201-2204, 2004
28. Osorio A, Rodriguez-Lopez R, Diez O, et al: The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population. Int J Cancer 108:54-56, 2004
29. Bernstein JL, Teraoka SN, John EM, et al: The CHEK2*1100delC allelic variant and risk of breast cancer: Screening results from the Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 15:348-352, 2006